An International Journal of Otorhinolaryngology Clinics

Register      Login

VOLUME 15 , ISSUE 3 ( September-December, 2023 ) > List of Articles

Original Article

A Clinicopathological Study of Cervical Lymphadenopathy

Ammu Korah, Girija Ghate, Rishikesh Pawar, Srinithya Kancherla

Keywords : Cervical lymphadenopathy, FNAC, Lymph node, Malignancy, Reactive, Tubercular

Citation Information : Korah A, Ghate G, Pawar R, Kancherla S. A Clinicopathological Study of Cervical Lymphadenopathy. Int J Otorhinolaryngol Clin 2023; 15 (3):125-127.

DOI: 10.5005/jp-journals-10003-1477

License: CC BY-NC 4.0

Published Online: 09-01-2024

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Background: Cervical lymphadenopathy is one among the common presentations in ENT OPD with its causes ranging from mild infections to life-threatening malignancies. Materials and methods: About 50 patients presenting to ENT OPD with cervical lymphadenopathy were selected after taking informed consent. Routine clinical laboratory and pathological investigations were done. Radiological investigations and open biopsy were done if required. Results: Reactive and malignancy cases accounted for the most cases, contributing 68% (34 out of 50) of all cases, or 34% each. Only a quarter of the cases (12 out of 50) were due to tuberculosis. Out of 50 cases, only two were diagnosed with lymphoma and nonspecific lymphadenitis. In this investigation, out of 50 cases, 44 cases diagnosed clinically matched the FNAC findings, whereas 6 cases were found to be different, resulting in 88% clinical diagnostic accuracy. And 43 of the radiologically diagnosed patients had the same FNAC diagnosis, while 7 of them differed on cytological analysis, resulting in 86% radiological diagnostic accuracy. Conclusion: Clinical evaluation followed by FNAC aids in the diagnosis of a case of cervical lymphadenopathy and can serve as a record for future care. For the diagnosis and treatment of the underlying cause, a thorough clinical examination and thorough investigations are required. If the diagnosis is delayed, the underlying cause may become incurable.


PDF Share
  1. Upadhyay N, Chaudhary A, Alok A. Cervical lymphadenopathy. J Dental Sci Oral Rehab 2012:30–33.
  2. Devendra KP, Rampal K, Prajapati JM. Research publications in ayurvedic sciences. Int J Allied Med Sci Clin Res 2016;4(3):560–565.
  3. Melkundi RS, Melkundi S. Clinicopathological study of cervical lymphadenopathy 2017;3(2):244–249. DOI: http://dx.doi.org/10.18203/issn.2454-5929.ijohns20170452.
  4. Ghate GA, Thomas J, Bhat N. A clinico-etiological study of cervical lymphadenopathy in otorhinolaryngology practice. Int J Otorhinolaryngol 2018;4(2):51–54. DOI: 10.11648/j.ijo.20180402.14.
  5. Gorle VK, Inamdar P. A clinicopathological study on cervical lymphadenopathy: An institutional experience 2018;5(8):2841–2845. DOI: 10.18203/2349-2902.isj20183201.
  6. Ashik Suresh. A clinicopathological study on cervical lymphadenopathy diss. Tirunelveli Medical College, Tirunelveli, 2017. Available from: http://repository-tnmgrmu.ac.in/id/eprint/4691.
  7. Biswas G, Das A, Haldar D, et al. Clinico-pathological correlates of cervical lymphadenopathy: A hospital based study. Indian J Otolaryngol Head Neck Surg 2013;65(Suppl 1):42–47. DOI: 10.1007/s12070-011-0443-z.
  8. Ramadas AA, Jose R, Varma B, et al. Cervical lymphadenopathy: Unwinding the hidden truth. Dent Res J (Isfahan) 2017;14(1):73–78. DOI: 10.4103/1735-3327.201136.
  9. Mili MK, Phookan J. A clinico-pathological study of cervical lymphadenopathy. Int J Dent Med Res 2015;1(5):24–27. DOI: https://doi.org/10.1007/s12070-016-1015-z.
  10. Sessions RB, Hudkins CP. Malignant Cervical Adenopathy. In: Cummings CW, Fredrickson JM, Harker LA et al., editors. Otolaryngology – Head and Neck Surgery. 2nd edition. Missouri: Mosby-year Book 1993. pp. 1610–1611.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.